Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Current Assets (2020 - 2022)

Atea Pharmaceuticals has reported Current Assets over the past 3 years, most recently at $681.9 million for Q3 2022.

  • Quarterly results put Current Assets at $681.9 million for Q3 2022, down 19.1% from a year ago — trailing twelve months through Sep 2022 was $681.9 million (down 19.1% YoY), and the annual figure for FY2021 was $772.4 million, down 10.55%.
  • Current Assets for Q3 2022 was $681.9 million at Atea Pharmaceuticals, down from $689.5 million in the prior quarter.
  • Over the last five years, Current Assets for AVIR hit a ceiling of $871.1 million in Q2 2021 and a floor of $108.4 million in Q3 2020.
  • Median Current Assets over the past 3 years was $772.4 million (2021), compared with a mean of $709.2 million.
  • Biggest five-year swings in Current Assets: surged 677.53% in 2021 and later decreased 20.85% in 2022.
  • Atea Pharmaceuticals' Current Assets stood at $863.5 million in 2020, then decreased by 10.55% to $772.4 million in 2021, then decreased by 11.71% to $681.9 million in 2022.
  • The last three reported values for Current Assets were $681.9 million (Q3 2022), $689.5 million (Q2 2022), and $713.2 million (Q1 2022) per Business Quant data.